IFGL Refractories

IFGL Refractories reported consolidated revenue growth of 23% YoYCurrent reported value: 23% YoY. No comparable prior figure is available in the source record. to ₹470 crore in Q3 FY26, driven by strong domestic (+17%) and US (+37%) performance. However, EBITDA margin contracted sharply to 5.3%Current reported value: 5.3%. No comparable prior figure is available in the source record. (vs 7.3% 9M FY26) due to elevated employee costs, product mix shifts, and one-time labor code expenses of ₹4.8 crore. Adjusted PAT was a mere ₹1.3 croreCurrent reported value: ₹1.3 crore. No comparable prior figure is available in the source record.. Management guided for gradual margin recovery to double-digit levels, with employee costs normalizing to ~10% of revenue. The UK subsidiary (Monocon) remains a drag, but cost optimization and new product uptake are expected to improve profitability. Key risks include sustained margin pressure from UK losses and potential delays in technology transfer from Sheffield. The MD's succession (James Macintosh stepping down effective March 1, 2026) adds leadership transition uncertainty.